Back

Randomized, Multicenter Comparison of Intensified versus Standard Loading Strategies with P2Y12-Receptor-Inhibitors in Patients Undergoing Elective PCI

2 September 2019 (09:42 - 10:00)
Organised by:
Congress Presentation Part of: Late Breaking Science in Intervention Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Julinda Mehilli

Hospital Landshut-Achdorf, Landshut (Germany)

4 More presentations in this session

Presentation thumbnail
Immediate versus Delayed Stenting After Primary Percutaneous Reperfusion in ST-Elevation Myocardial Infarction: The PRIMACY Bayesian Randomized Controlled Trial
Doctor M. Jolicoeur (Montreal, CA)
Slides Video
Presentation thumbnail
Percutaneous left atrial appendage closure versus novel anticoagulation agents in high-risk atrial fibrillation patients (PRAGUE-17 study)
Doctor P. Osmancik (Prague, CZ)
Slides Video
Presentation thumbnail
Ultrathin-strut biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in acute myocardial infarction: a randomized controlled trial
Doctor J. Iglesias (Geneva, CH)
Slides Video
Presentation thumbnail
Low-dose rivaroxaban after left atrial appendage closure: The randomized ADRIFT study
Professor G. Montalescot (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Intervention

The Event

Event poster

ESC Congress 2019

2 September 2019 09:42 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of the antiplatelet effect of different p2y12 inhibitors using two methods at 30 and 120 minutes after oral loading in the cardiac catheterization laboratory
21 March 2026
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Upgrading the STEMI emergency kit: a meta-analysis of randomized controlled trials
30 August 2025
thumbnail
Congress Presentation
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome and multivessel coronary artery disease: a post-hoc analysis of the TROPICAL-ACS trial
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources